It is part of a pre-defined gene set under the regulation of hypoxia inducible factor 1 alpha (HIF-1α) in breast cancer and there is a positive correlation between the expression of HIF-1α and MCU in-vitro seemingly found also in clinical data [59]. The gene discussed is HIF1A; the disease is breast carcinoma.